Product Name: Human HGF / SF Antibody (Rilotumumab, Research Use)
Catalog Number: NBR-0201
Target Name: HGF / SF
Trade Name: Rilotumumab
Antibody Drug Description: Rilotumumab is a fully human IgG2 monoclonal antibody directed against the human hepatocyte growth factor (HGF) with potential antineoplastic activity. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: HGF / SF
Synonyms: DFNB39; F-TCF; HGFB; HPTA; SF
Target Description: Potent mitogen for mature parenchymal hepatocyte cells, seems to be a hepatotrophic factor, and acts as a growth factor for a broad spectrum of tissues and cell types. Activating ligand for the receptor tyrosine kinase MET by binding to it and promoting its dimerization.
Ensembl: ENSG00000019991 
Uniprot: P14210